The Community Guide

- gsearch

Search Results

Narrow Results:

2021 1
2017 1
2016 1
2014 2
2012 1
2011 2

Journal Article 8

1 - 8 of 8 Results

Refine Results

Refine Results:

Media matters: Modeling the impact of solid media performance on tuberculosis trial sample size requirements

CITE Title : Media matters: Modeling the impact of solid media performance on tuberculosis trial sample size requirements Personal Author(s) : Johnson, Matthew G.;Stout, Jason E.;Benator, Debra A.;Whitworth, William C.;Holland, David P.; Published Date : 2016 May Source : Int J Tuberc Lung Dis. 20(5):600-604 URL : https://stacks.cdc.gov/view/cdc/40497 Johnson, Matthew G. et al. (2016). Media matters: Modeling the impact of solid media performance on tuberculosis trial sample size requirements. 20(5). Johnson, Matthew G. et al. "Media matters: Modeling the impact of solid media performance on tuberculosis trial sample size requirements" 20, no. 5 (2016) Johnson, Matthew G. et al. "Media matters: Modeling the impact of solid media performance on tuberculosis trial sample size requirements" vol. 20, no. 5, 2016 Export RIS Citation Information.

:

Johnson, Matthew G. ;

Stout, Jason E.

2016 May | Int J Tuberc Lung Dis. 20(5):600-604

:

SettingTwo-month solid media culture conversion is a commonly used (if suboptimal) endpoint for phase 2 tuberculosis treatment trials.Objective and De...
Defining the Optimal Dose of Rifapentine for Pulmonary Tuberculosis: Exposure-Response Relations From Two Phase 2 Clinical Trials

CITE Title : Defining the Optimal Dose of Rifapentine for Pulmonary Tuberculosis: Exposure-Response Relations From Two Phase 2 Clinical Trials Personal Author(s) : Savic, Radojka M.;Weiner, Marc;Mac Kenzie, William R.;Engle, Melissa;Whitworth, William C.;Johnson, John L.;Nsubuga, Pheona;Nahid, Payam;Nguyen, Nhung Viet;Peloquin, Charles A.;Dooley, Kelly E.;Dorman, Susan E.; Corporate Authors(s) : for the Tuberculosis Trials Consortium of the Centers for Disease Control and Prevention Published Date : Mar 02 2017 Source : Clin Pharmacol Ther. 102(2):321-331. URL : https://stacks.cdc.gov/view/cdc/47441 Savic, Radojka M. et al. (2017). Defining the Optimal Dose of Rifapentine for Pulmonary Tuberculosis: Exposure-Response Relations From Two Phase 2 Clinical Trials. 102(2). Savic, Radojka M. et al. "Defining the Optimal Dose of Rifapentine for Pulmonary Tuberculosis: Exposure-Response Relations From Two Phase 2 Clinical Trials" 102, no. 2 (2017) Savic, Radojka M. et al. "Defining the Optimal Dose of Rifapentine for Pulmonary Tuberculosis: Exposure-Response Relations From Two Phase 2 Clinical Trials" vol. 102, no. 2, 2017 Export RIS Citation Information.

:

Savic, Radojka M. ;

Weiner, Marc

Mar 02 2017 | Clin Pharmacol Ther. 102(2):321-331.

:

Rifapentine is a highly active antituberculosis antibiotic with treatment-shortening potential; however, exposure-response relations and the dose need...
Tuberculin Skin Tests versus Interferon-Gamma Release Assays in Tuberculosis Screening among Immigrant Visa Applicants

CITE Title : Tuberculin Skin Tests versus Interferon-Gamma Release Assays in Tuberculosis Screening among Immigrant Visa Applicants Personal Author(s) : Chuke, Stella O.;Yen, Nguyen Thi Ngoc;Laserson, Kayla F.;Phuoc, Nguyen Huu;Trinh, Nguyen An;Nhung, Duong Thi Cam;Mai, Vo Thi Chi;Qui, An Dang;Hai, Hoang Hoa;Loan, Le Thien Huong;Jones, Warren G.;Whitworth, William C.;Shah, J. Jina;Painter, John A.;Mazurek, Gerald H.;Maloney, Susan A.; Published Date : Mar 06 2014 Source : Tuberc Res Treat. 2014; 2014. URL : https://stacks.cdc.gov/view/cdc/27693 Chuke, Stella O. et al. (2014). Tuberculin Skin Tests versus Interferon-Gamma Release Assays in Tuberculosis Screening among Immigrant Visa Applicants. 2014 Chuke, Stella O. et al. "Tuberculin Skin Tests versus Interferon-Gamma Release Assays in Tuberculosis Screening among Immigrant Visa Applicants" 2014 (2014) Chuke, Stella O. et al. "Tuberculin Skin Tests versus Interferon-Gamma Release Assays in Tuberculosis Screening among Immigrant Visa Applicants" vol. 2014, 2014 Export RIS Citation Information.

:

Chuke, Stella O. ;

Yen, Nguyen Thi Ngoc

Mar 06 2014 | Tuberc Res Treat. 2014; 2014.

:

Objective. Use of tuberculin skin tests (TSTs) and interferon gamma release assays (IGRAs) as part of tuberculosis (TB) screening among immigrants fro...
Central Monitoring in a randomized, open-label, controlled phase 3 clinical trial for a treatment-shortening regimen for pulmonary tuberculosis

CITE Title : Central Monitoring in a randomized, open-label, controlled phase 3 clinical trial for a treatment-shortening regimen for pulmonary tuberculosis Personal Author(s) : Bryant, Kia E.;Yuan, Yan;Engle, Melissa;Kurbatova, Ekaterina V.;Allen-Blige, Cynthia;Batra, Kumar;Brown, Nicole E.;Chiu, Kuo wei;Davis, Howard;Elskamp, Mascha;Fagley, Melissa;Fedrick, Pamela;Hedges, Kimberly NC;Narunsky, Kim;Nassali, Joanita;Phan, Mimi;Phan, Ha;Purfield, Anne E.;Ricaldi, Jessica N.;Robergeau-Hunt, Kathleen;Whitworth, William C.;Sizemore, Erin E.; Corporate Authors(s) : AIDS Clinical Trials Group and the Tuberculosis Trials Consortium Published Date : 5 2021 Source : Contemp Clin Trials. 104:106355 URL : https://stacks.cdc.gov/view/cdc/116842 Bryant, Kia E. et al. (2021). Central Monitoring in a randomized, open-label, controlled phase 3 clinical trial for a treatment-shortening regimen for pulmonary tuberculosis. 104 Bryant, Kia E. et al. "Central Monitoring in a randomized, open-label, controlled phase 3 clinical trial for a treatment-shortening regimen for pulmonary tuberculosis" 104 (2021) Bryant, Kia E. et al. "Central Monitoring in a randomized, open-label, controlled phase 3 clinical trial for a treatment-shortening regimen for pulmonary tuberculosis" vol. 104, 2021 Export RIS Citation Information.

:

Bryant, Kia E. ;

Yuan, Yan

5 2021 | Contemp Clin Trials. 104:106355

:

Introduction:With the growing use of online study management systems and rapid availability of data, timely data review and quality assessments are ne...
Within-Subject Interlaboratory Variability of QuantiFERON-TB Gold In-Tube Tests

CITE Title : Within-Subject Interlaboratory Variability of QuantiFERON-TB Gold In-Tube Tests Personal Author(s) : Whitworth, William C.;Hamilton, Lanette R.;Goodwin, Donald J.;Barrera, Carlos;West, Kevin B.;Racster, Laura;Daniels, Laura J.;Chuke, Stella O.;Campbell, Brandon H.;Bohanon, Jamaria;Jaffar, Atheer T.;Drane, Wanzer;Maserang, David;Mazurek, Gerald H.; Published Date : Sep 06 2012 Source : PLoS One. 2012; 7(9). URL : https://stacks.cdc.gov/view/cdc/10932 Whitworth, William C. et al. (2012). Within-Subject Interlaboratory Variability of QuantiFERON-TB Gold In-Tube Tests. 7(9). Whitworth, William C. et al. "Within-Subject Interlaboratory Variability of QuantiFERON-TB Gold In-Tube Tests" 7, no. 9 (2012) Whitworth, William C. et al. "Within-Subject Interlaboratory Variability of QuantiFERON-TB Gold In-Tube Tests" vol. 7, no. 9, 2012 Export RIS Citation Information.

:

Whitworth, William C. ;

Hamilton, Lanette R.

Sep 06 2012 | PLoS One. 2012; 7(9).

:

BackgroundThe QuantiFERON®-TB Gold In-Tube test (QFT-GIT) is a viable alternative to the tuberculin skin test (TST) for detecting Mycobacterium tuber...
Multiple Cytokines Are Released When Blood from Patients with Tuberculosis Is Stimulated with Mycobacterium tuberculosis Antigens

CITE Title : Multiple Cytokines Are Released When Blood from Patients with Tuberculosis Is Stimulated with Mycobacterium tuberculosis Antigens Personal Author(s) : Kellar, Kathryn L.;Gehrke, Jennifer;Weis, Stephen E.;Mahmutovic-Mayhew, Aida;Davila, Blachy;Zajdowicz, Margan J.;Scarborough, Robin;LoBue, Philip A.;Lardizabal, Alfred A.;Daley, Charles L.;Reves, Randall R.;Bernardo, John;Campbell, Brandon H.;Whitworth, William C.;Mazurek, Gerald H.; Published Date : Nov 21 2011 Source : PLoS One. 2011; 6(11). URL : https://stacks.cdc.gov/view/cdc/4346 Kellar, Kathryn L. et al. (2011). Multiple Cytokines Are Released When Blood from Patients with Tuberculosis Is Stimulated with Mycobacterium tuberculosis Antigens. 6(11). Kellar, Kathryn L. et al. "Multiple Cytokines Are Released When Blood from Patients with Tuberculosis Is Stimulated with Mycobacterium tuberculosis Antigens" 6, no. 11 (2011) Kellar, Kathryn L. et al. "Multiple Cytokines Are Released When Blood from Patients with Tuberculosis Is Stimulated with Mycobacterium tuberculosis Antigens" vol. 6, no. 11, 2011 Export RIS Citation Information.

:

Kellar, Kathryn L. ;

Gehrke, Jennifer

Nov 21 2011 | PLoS One. 2011; 6(11).

:

BackgroundMycobacterium tuberculosis (Mtb) infection may cause overt disease or remain latent. Interferon gamma release assays (IGRAs) detect Mtb infe...
Variability of the QuantiFERON®-TB Gold In-Tube Test Using Automated and Manual Methods

CITE Title : Variability of the QuantiFERON®-TB Gold In-Tube Test Using Automated and Manual Methods Personal Author(s) : Whitworth, William C.;Goodwin, Donald J.;Racster, Laura;West, Kevin B.;Chuke, Stella O.;Daniels, Laura J.;Campbell, Brandon H.;Bohanon, Jamaria;Jaffar, Atheer T.;Drane, Wanzer;Sjoberg, Paul A.;Mazurek, Gerald H.; Published Date : Jan 23 2014 Source : PLoS One. 2014; 9(1). URL : https://stacks.cdc.gov/view/cdc/27900 Whitworth, William C. et al. (2014). Variability of the QuantiFERON®-TB Gold In-Tube Test Using Automated and Manual Methods. 9(1). Whitworth, William C. et al. "Variability of the QuantiFERON®-TB Gold In-Tube Test Using Automated and Manual Methods" 9, no. 1 (2014) Whitworth, William C. et al. "Variability of the QuantiFERON®-TB Gold In-Tube Test Using Automated and Manual Methods" vol. 9, no. 1, 2014 Export RIS Citation Information.

:

Whitworth, William C. ;

Goodwin, Donald J.

Jan 23 2014 | PLoS One. 2014; 9(1).

:

BackgroundThe QuantiFERON®-TB Gold In-Tube test (QFT-GIT) detects Mycobacterium tuberculosis (Mtb) infection by measuring release of interferon gamma...
Unusual Interferon Gamma Measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube Tests

CITE Title : Unusual Interferon Gamma Measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube Tests Personal Author(s) : Powell, Richard D.;Whitworth, William C.;Bernardo, John;Moonan, Patrick K.;Mazurek, Gerald H.; Published Date : Jun 08 2011 Source : PLoS One. 2011; 6(6). URL : https://stacks.cdc.gov/view/cdc/4327 Powell, Richard D. et al. (2011). Unusual Interferon Gamma Measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube Tests. 6(6). Powell, Richard D. et al. "Unusual Interferon Gamma Measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube Tests" 6, no. 6 (2011) Powell, Richard D. et al. "Unusual Interferon Gamma Measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube Tests" vol. 6, no. 6, 2011 Export RIS Citation Information.

:

Powell, Richard D. ;

Whitworth, William C.

Jun 08 2011 | PLoS One. 2011; 6(6).

:

IntroductionInterferon gamma (IFN-γ) release assays, such as QuantiFERON®-TB Gold test (QFT-G) and QuantiFERON®-TB Gold In-Tube test (QFT-GIT) are ...